| # | Drug | Count |
|---|---|---|
| 0 | HYDROXYCHLOROQUINE | 15 |
| 1 | CYCLOPHOSPHAMIDE | 8 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 8 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 8 |
| 4 | FLUOXETINE HYDROCHLORIDE | 7 |
| 5 | AZATHIOPRINE | 6 |
| 6 | TADALAFIL | 6 |
| 7 | FLUOXETINE | 5 |
| 8 | MACITENTAN | 5 |
| 9 | MYCOPHENOLATE MOFETIL | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LECANEMAB-IRMB | 1 | 0.0588 |
| 1 | NITRIC OXIDE | 1 | 0.0002 |
| 2 | RITUXIMAB-ABBS | 1 | 0.0002 |
| 3 | SELEXIPAG | 5 | 0.0002 |
| 4 | CLOFAZIMINE | 1 | 0.0002 |
| 5 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 1 | 0.0001 |
| 6 | ANAKINRA | 2 | 0.0001 |
| 7 | DEFERASIROX | 2 | 0.0001 |
| 8 | REMDESIVIR | 1 | 0.0001 |
| 9 | MACITENTAN | 5 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 1 | Prostacyclin Receptor Agonist [EPC] | 5 | 0.0002 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Iron Chelator [EPC] | 2 | 0.0001 |
| 5 | Purine Antimetabolite [EPC] | 6 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Antimycobacterial [EPC] | 1 | 0.0000 |